Liver Disease Information
In Your Area
We're staffed 9am-7pm ET, Mon-Fri
American Liver Foundation
39 Broadway, Suite 2700
New York, New York 10006
Browse Related Terms
Help Fight Liver Disease
Alpha-1 Antitrypsin Deficiency In The News
Childhood Liver Disease Research & Education Network
The Childhood Liver Disease Research & Education Network (ChiLDREN) is a collaborative team of doctors, nurses, research coordinators, and patient support organizations working together to improve the lives of children and families dealing with rare liver diseases.
Explore this section to learn more about alpha-1 antitrypsin deficiency, including a description of the disorder and how it's diagnosed.
What is Alpha-1 Antitrypsin Deficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a hereditary genetic disorder which may lead to the development of lung and/or liver disease. It is the most common genetic cause of liver disease in children. Adults can also be affected by Alpha-1 and may develop lung conditions such as emphysema as well as liver problems. Fortunately, many persons diagnosed with Alpha-1 never develop any of the associated diseases.
What are the symptoms of Alpha-1 Antitrypsin Deficiency?
In newborns, the typical symptoms of Alpha-1 are jaundice, swelling of the abdomen, and poor feeding. Alpha-1 may also appear in late childhood or adulthood and be detected because of fatigue, poor appetite, swelling of the abdomen and legs or abnormal liver tests.
What causes Alpha-1 Antitrypsin Deficiency?
Alpha-1 antitrypsin is a protein made in the liver which plays an important role in preventing the breakdown of enzymes in various organs. Individuals with Alpha-1 have a genetic disorder that prevents their body from creating enough of this protein. This trait must be inherited from both parents (who are, by definition, carriers) in order to cause the disorder.
How is Alpha-1 Antitrypsin Deficiency diagnosed?
The diagnosis of Alpha-1 is made by blood tests showing the low levels of alpha-1 antitrypsin and abnormal liver tests. Other tests such as ultrasound imaging or tests using specialized X-ray techniques may be necessary. A liver biopsy may be performed to check for damage to the liver.
How is Alpha-1 Antitrypsin Deficiency treated?
Currently, there is no cure for Alpha-1. Treatment is designed to maintain normal nutrition, to provide the liver and the body with essential nutrients, and to identify complications early in order to treat them better. Multiple vitamins and vitamins E, D, and K are often given. Certain abnormalities can be treated or controlled. Jaundice, severe itching, and fluid retention can all be dealt with through medication.
If I or my child has been diagnosed with Alpha-1 Antitrypsin Deficiency, what should I ask my doctor?
Speak with your doctor about the particular symptoms you are experiencing and the best methods for treating them. Also discuss the best ways to check for future progression of the disease.
Who is at risk for Alpha-1 Antitrypsin Deficiency?
Worldwide, approximately 1 in 2,500 individuals has Alpha-1 Antitrypsin Deficiency. This disorder is found in all ethnic groups; however, it occurs most frequently in whites of European ancestry.
© Copyright 2017 American Liver Foundation. All Rights Reserved. The American Liver Foundation is included in CharityWatch’s 2016 list of Top-Rated Charities and is a Member of the World Hepatitis Alliance.